Showing results (21-30 of 30) with videos related to

Sort By:
Pageof 3
You have reached the last page of results.This site can display upto 30 results.
Journal of Medical Genetics|July 14, 2019
One in three highly selected Greek patients with breast cancer carries a loss-of-function variant in a cancer susceptibility geneFlorentia Fostira, Irene Kostantopoulou, Paraskevi Apostolou, et al.
Acta Oncologica (Stockholm, Sweden)|May 18, 2021
AGAPP: efficacy of first-line cisplatin, 5-fluorouracil with afatinib in inoperable gastric and gastroesophageal junction carcinomas. A Hellenic Cooperative Oncology Group studyGeorge Zarkavelis, Epaminontas Samantas, Georgia-Angeliki Koliou, et al.
British Journal of Cancer|May 19, 2018
Impact of timing of trastuzumab initiation on long-term outcome of patients with early-stage HER2-positive breast cancer: the "one thousand HER2 patients" projectGiuseppe Gullo, Naomi Walsh, David Fennelly, et al.
BMC Cancer|October 1, 2025
Real-world management strategies and clinical outcomes of metastatic HER2-positive breast cancer in Greece in the second-line setting and beyond (the togetHER study)Ippokratis Korantzis, Anna Koumarianou, Vassiliki Rapti, et al.
Cancers|August 14, 2025
Real-World Toxicity and Effectiveness Study of Abemaciclib in Greek Patients with Hormone Receptor-Positive/Human Epidermal Growth Factor Receptor 2-Negative Breast Cancer: A Multi-Institutional StudyElena Fountzilas, Eleni Aravantinou-Fatorou, Katerina Dadouli, et al.
Anticancer Research|December 1, 2022
Genetic Predisposition to Male Breast Cancer: A Case SeriesAngela Apessos, Konstantinos Agiannitopoulos, Georgia Pepe, et al.
Oncology Letters|December 6, 2021
mRNA expression of specific HER ligands and their association with clinical outcome in patients with metastatic breast cancer treated with trastuzumabVassiliki Rapti, Evangelia Moirogiorgou, Georgia-Angeliki Koliou, et al.
Cancers|May 27, 2026
Germline Genetic Testing in Breast and Gynecologic Cancers: Evaluating Age at Diagnosis as a DeterminantEirini Papadopoulou, Georgios N Tsaousis, Romina Alevizou, et al.
ESMO Open|August 21, 2020
Real-world clinical outcome and toxicity data and economic aspects in patients with advanced breast cancer treated with cyclin-dependent kinase 4/6 (CDK4/6) inhibitors combined with endocrine therapy: the experience of the Hellenic Cooperative Oncology GroupElena Fountzilas, Georgia-Angeliki Koliou, Athanassios Vozikis, et al.
Therapeutic Advances in Medical Oncology|August 7, 2019
Pilot study of bevacizumab in combination with docetaxel and cyclophosphamide as adjuvant treatment for patients with early stage HER-2 negative breast cancer, including analysis of candidate circulating markers of cardiac toxicity: ICORG 08-10 trialGiuseppe Gullo, Alex J Eustace, Alexandra Canonici, et al.
Pageof 3